Management Decision DSM Successfully Completes Acquisition of Erber Group
Royal DSM has completed the acquisition of the Erber Group for 1,149 million dollars. The deal includes the Group’s Biomin as well as Romer Labs business. The Biomin business is expected to further strengthen DSM’s expertise in animal health and nutrition solutions whereas Romer Labs complements DSM’s human nutrition and health offering to customers in the food & beverages industry.
Heerlen/The Netherlands – Royal DSM has recently announced the completion of its acquisition of Erber Group for an enterprise value of 1,149 million dollars. The transaction— which excludes two smaller units in the Erber Group—is expected to be earnings enhancing in the first year upon completion. The acquisition of Erber Group was first announced on June 12, 2020.
DSM acquired Erber Group’s Biomin and Romer Labs. Erber Group’s specialty animal nutrition and health business Biomin specialises primarily in mycotoxin risk management and gut health performance management, whereas the Romer Labs business focuses on food and feed safety diagnostic solutions. Both expand DSM’s range of higher value-add specialty solutions.
The acquisition of Erber Group’s Biomin further strengthens DSM’s expertise and reputation as a leading provider of animal health and nutrition solutions for farm productivity and sustainability, with an emphasis on emissions reduction, feed consumption efficiency, and better use of water and land. It is therefore very much aligned with DSM’s focus to make animal farming more sustainable from both an ecological and economical perspective. Romer Labs also complements DSM’s human nutrition and health offering to customers in the food & beverages market segments.